Acer Therapeutics (ACER) News Today → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free ACER Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVehicle crashes into North Avenue restaurantmsn.com - May 1 at 5:16 PMArrest made following shots fired incident on Vann Avenuemsn.com - April 30 at 12:48 AMZevra Therapeutics' President and Chief Executive Officer Issues Letter to Stockholders Highlighting Recent Key Accomplishments and Outlook for 2024finanznachrichten.de - April 29 at 2:06 PM2 hospitalized after double shooting on Hudson Avenue in Rochestermsn.com - April 28 at 2:39 PMFBI was on scene of incident in Portsmouth on Broomhill Avenuemsn.com - April 27 at 5:34 PMCrews responding to structure fire on Spruill Avenuemsn.com - April 26 at 4:32 PMFBI was scene of incident in Portsmouth on Broomhill Avenuemsn.com - April 26 at 4:32 PMKohr Explores: 82nd Avenue of Roses Parade takes to the streets Saturdaymsn.com - April 26 at 11:31 AMNorth Avenue closuremsn.com - April 26 at 6:29 AMFire crews on the scene of Denby Avenue structure firemsn.com - April 26 at 6:29 AMMan killed in hit-and-run on Jackson Avenuemsn.com - April 25 at 9:36 AMZevra Therapeutics Inc (ZVRA) Earnings: A Mixed Bag Against Analyst Estimates with Significant ...uk.finance.yahoo.com - March 28 at 7:37 PMHow to score 50% off The Legend of Zelda: Breath of the Wildmsn.com - February 22 at 10:32 AMAcer Therapeutics Inc Stock (OTC:ACER), Guidance and Forecastbenzinga.com - January 6 at 3:15 AMAcer Therapeutics Inc Stock (OTC:ACER) Dividends: History, Yield and Datesbenzinga.com - January 6 at 3:15 AMZevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officerfinance.yahoo.com - January 4 at 10:09 AMRelief Therapeutics Holding SA RLFmorningstar.com - December 31 at 12:02 AMAcer Therapeutics Stock (NASDAQ:ACER) Insider Tradesbenzinga.com - November 18 at 7:45 AMZevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Resultsmarkets.businessinsider.com - November 7 at 8:31 AMZevra Therapeutics Inc (ZVRA) Reports Q3 2023 Financial Resultsfinance.yahoo.com - November 7 at 8:31 AMLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposalsfinance.yahoo.com - November 2 at 9:00 AMAcer Therapeutics Inc. (ACER)sg.finance.yahoo.com - November 1 at 2:14 PMHC Wainwright Downgrades Acer Therapeutics247wallst.com - September 6 at 4:35 PMRoth MKM Downgrades Acer Therapeutics247wallst.com - September 5 at 8:50 PMZevra's Rare Find: Unearthing Value In Niche Rare Diseases The Market Overlooksmsn.com - September 5 at 3:45 AMRoth Capital Downgrades Acer Therapeutics (ACER)msn.com - September 2 at 5:10 PMRoth MKM Downgrades Acer Therapeutics (ACER)msn.com - September 2 at 6:48 AMAcer (ACER) to Get Acquired by Zevra for $91M, Stock Upmsn.com - September 1 at 10:43 AMAcer Therapeutics will reacquire OLPRUVA rights from Relief Therapeuticsmsn.com - September 1 at 5:42 AMZevra Therapeutics to Buy Acer Therapeutics >ZVRA ACERmarketwatch.com - August 31 at 7:41 PMUS Stocks Rise; Initial Jobless Claims Edge Lowermarkets.businessinsider.com - August 31 at 2:41 PMWhy Is Acer Therapeutics Stock Trading Higher Today?msn.com - August 31 at 2:41 PMACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholderstechnews.tmcnet.com - August 31 at 2:41 PMAcer Therapeutics Shares Take Flight on Zevra Dealmarketwatch.com - August 31 at 2:41 PMAcer Therapeutics surges as Zevra agrees to acquire for up to $91Mseekingalpha.com - August 31 at 2:41 PMZerva acquires Acer Therapeutics to bolster rare disease portfoliomsn.com - August 31 at 2:41 PMAcer Therapeutics (NASDAQ:ACER) Skyrockets on Acquisition by Zevra Therapeuticsmsn.com - August 31 at 2:41 PMZevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Productfinance.yahoo.com - August 31 at 2:41 PMStruggling Newton biotech Acer Therapeutics scooped up by Florida firmfinance.yahoo.com - August 31 at 2:41 PMmarketbeat.com - August 31 at 9:54 AMmarketbeat.com - August 31 at 9:49 AMRelief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA (ACER-001) with Acer Therapeuticsmarkets.businessinsider.com - August 30 at 6:59 PMAcer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europefinance.yahoo.com - August 30 at 6:59 PMAcer Therapeutics Inc.: Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - August 16 at 4:44 AMAcer Therapeutics, funded almost entirely by its own CEO, has weeks to livefinance.yahoo.com - August 15 at 6:43 PMAcer Therapeutics GAAP EPS of -$0.33msn.com - August 14 at 9:27 PMAcer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 14 at 4:27 PMAcer Therapeutics Inc.: Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founderfinanznachrichten.de - June 26 at 2:06 PMAcer Therapeutics CEO infuses $1M into company in exchange for promissory noteseekingalpha.com - June 26 at 2:06 PMAcer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founderfinance.yahoo.com - June 26 at 9:06 AM Get Acer Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… ACER Media Mentions By Week ACER Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACER News Sentiment▼-0.350.36▲Average Medical News Sentiment ACER News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACER Articles This Week▼01▲ACER Articles Average Week Get Acer Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NeuroBo Pharmaceuticals News Cocrystal Pharma News VBI Vaccines News FSD Pharma News Minerva Neurosciences News Aytu BioPharma News Vaxxinity News Tonix Pharmaceuticals News Orgenesis News Talphera News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACER) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acer Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
